While many individuals are genetically predisposed to neurodegenerative diseases like Alzheimer's (AD) and Parkinson's (PD), translating these genetic vulnerabilities into effective therapies remains a major challenge. Traditional research systems often fail to capture uniquely human brain biology, hindering the discovery of underlying cellular mechanisms. To address this unmet need, induced...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt